Measles virus entry inhibitors: a structural proposal for mechanism of action and the development of resistance.
Previously, we developed a panel of nonpeptidic compounds specifically preventing fusion of the measles virus (MV) with target cells at IC(50) values of 0.6-3 muM. Mutations in the MV fusion protein (MV F) that render resistance to these blockers were described. The structural basis for both inhibition and resistance was unclear in the earlier work because of the availability of a structural model for only the postfusion conformation of MV F. We have now developed structural models for both pre- and postfusion conformers of the latter protein trimer. The models allow investigation of the large-scale conformational changes occurring in the MV fusion machinery and, in conjunction with antisera binding studies, provide a rationale for how inhibitors may arrest a conformational intermediate by interfering with the formation of interactions between the heptad repeat B (HR-B) linker and DIII domains. The models also show that resistance to inhibition can be explained by a predicted destabilizing effect of the mutations on the HR-B domain within the trimeric prefusion structure. This viewpoint is supported by the temperature-dependent differential fusion activities of MV F variants harboring these mutations.
Prussia
Andrew J
AJ
Department of Chemistry, Emory University, Atlanta, Georgia 30322, USA.
Plemper
Richard K
RK
Snyder
James P
JP
D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry* / Q000378:metabolism; D002522:Chlorocebus aethiops; D003198:Computer Simulation; D019281:Dimerization; D024882:Drug Resistance, Viral; D020128:Inhibitory Concentration 50; D008459:Measles virus / Q000378:metabolism*; D008958:Models, Molecular; D008968:Molecular Conformation; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D014709:Vero Cells
D000998:Antiviral Agents